Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Illumina, Abbott, Roche, Rheonix, Firefly, Others Win US Patents


Lawrence Livermore National Security and The University of California have been awarded US Patent No. 8,610,032, "Laser heating of aqueous samples on a micro-optical-electro-mechanical system."

Neil Beer and Ian Kennedy are named as inventors.

Ibis Biosciences (Abbott Laboratories) has been awarded US Patent No. 8,609,430, "Sample processing units, systems, and related methods."

Steven Hofstadler, Jared Drader, Jose Gutierrez, Paul Gleason, Rex Bare, Robert Miller, and Jeffrey Smith are named as inventors.

Illumina has been awarded US Patent No. 8,609,341, "Uniform fragmentation of DNA using binding proteins."

Frank Steemers and Jonathan Boutell are named as inventors.

Roche has been awarded US Patent No. 8,609,340, "Control nucleic acids for multiple parameters."

Meike Eickhoff, Ellen Fiss, Joachim Glaubitz, Niclas Hitziger, Stephen Will, and Dirk Zimmermann are named as inventors.

454 Life Sciences (Roche) has been awarded US Patent No. 8,609,339, "System and method for emulsion breaking and recovery of biological elements."

Yue Suo is named as the inventor.

Firefly BioWorks has been awarded US Patent No. 8,609,337, "Nucleic acid detection and quantification by post-hybridization labeling and universal encoding."

Daniel Pregibon, Isaac Stoner, Andreas Windemuth, and Timothy Erps are named as inventors.

Rheonix has been awarded US Patent No. 8,609,039, "Microfluidic systems and control methods."

Peng Zhou and Lincoln Young are named as inventors.

The University of British Columbia has been awarded US Patent No. 8,608,929, "Apparatus and methods for concentrating and separating particles such as molecules."

Andrea Marziali and David Broemeling are named as inventors.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.